MannKind | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Adma Biologics USD 349.02M 117.13M 2024-12
Dynavax Technologies USD 494.16M 36.78M 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Halozyme Therapeutics USD 332.75M 149.52M 2025-06
Insmed USD 1.25B 1.15B 2025-06
MacroGenics USD 116.06M 4.01M 2024-12
MannKind USD -55042000 3.58M 2025-06
Merck USD 49.06B 725M 2025-06
Novo Nordisk DKK 138.54B 18.02B 2025-03
Pfizer USD 88.7B 1.64B 2025-06
Sanofi 70.28B 3.8B 2025-06
Xencor USD 620.35M 19.52M 2025-06


MannKind Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.